Search Results 151-160 of 3297 for Orf
TRK-250 is a nucleic acid medicine that inhibits the progression of pulmonary fibrosis by selectively suppressing the expression of transforming growth factor- ...
The study also aims to identify any clinical, laboratory, echocardiographic, imaging, and hemodynamic parameters that connect with improved outcomes of cardiac ...
Mayo Clinic and Mercy reach first major milestone in data collaboration. Decades of data can now be used to pinpoint diseases earlier and transform ...
Wood CM, Cortopassi IO, McCann MR, Mergo PJ, Stowell JT, Little BP. Psychological and Behavioral Factors in Lung Cancer Screening Uptake and Adherence: ...
Mayo Clinic Comprehensive Cancer Center to highlight key studies at ASCO 2024. Kelley Luckstein. May 30, 2024. Mayo Clinic Minute: Benefits of an active ...
African Americans, Afro-Caribbeans, Hispanic Blacks, and Africans are more likely to have the APOL1 gene variants that cause kidney disease. APOLLO will test ...
Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, Florida and Minnesota. Staff skilled in dozens ...
Video: A healthy liver transitions to cirrhosis, illustrating a potential outcome of metabolic dysfunction-associated steatotic liver disease — formerly ...
The need for better options in diabetes care inspires Kyle Knofczynski, a student in the Regenerative Sciences Ph.D. track at the Mayo Clinic Graduate ...
Mayo Clinic treats first person in the US with a novel radiopharmaceutical therapy for breast cancer. Researchers are leading the nation in using powerful ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.